GlassScriptPhysician profile
Allen Daniel Nicholson
NPI 1184002230
$20,266.27
in general payments reported to CMS, 2019-2025
10 companies · $1,873 in 2025
The $1,873 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $10K · 2021: $1,040 · 2022: $7,037 · 2023: $141 · 2024: $175 · 2025: $1,873.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,406 · Travel and Lodging: $783.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,406.03 |
| Travel and Lodging | $782.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $12,896.68 | 2020-2022 | |
| Zimmer Biomet Holdings, INC. | $4,045.48 | 2022-2025 | Comprehensive Shoulder System, Maxbraid, Tricera Handpiece |
| Seapearl East, INC | $1,482.92 | 2022-2024 | |
| Stryker Corporation | $1,240.17 | 2021-2025 | Blueprint Patient Specific Instrumentation, Mako, Inspace |
| Catalyst Orthoscience | $435.67 | 2021 | |
| Medacta USA, INC. | $85.71 | 2022 | |
| Bioventus LLC | $32.61 | 2021-2024 | Durolane |
| Depuy Synthes Sales INC. | $20.15 | 2024 | Orthovisc, Monovisc |
| Smith+Nephew, INC. | $13.83 | 2025 | Aetos Shoulder System, Twinfix |
| Sanofi-Aventis U.S. LLC | $13.05 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allen Nicholson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.